"Philips Halts Sales of Sleep Apnea Machines in US Amid Safety Concerns"

Philips, the company behind a global recall of sleep apnea machines, has agreed to stop selling the devices in the U.S. due to risks associated with their internal foam breaking down over time. The tentative agreement with regulators could cost the manufacturer nearly $400 million, and Philips has agreed to a consent decree with the FDA and the Department of Justice. The company will continue servicing previously sold machines in the U.S. but cannot sell new ones until it meets corrective actions laid out by the FDA. The recall affects over 5 million pressurized breathing machines, and the company faces personal injury lawsuits related to the devices.